{"id":"https://openalex.org/W2439951792","doi":"https://doi.org/10.1097/jcp.0000000000000372","title":"Medication Nonadherence, \u201cProfessional Subjects,\u201d and Apparent Placebo Responders: Overlapping Challenges for Medications Development","display_name":"Medication Nonadherence, \u201cProfessional Subjects,\u201d and Apparent Placebo Responders: Overlapping Challenges for Medications Development","alternate_titles":[],"publication_year":2015,"publication_date":"2015-08-05","ids":{"openalex":"https://openalex.org/W2439951792","doi":"https://doi.org/10.1097/jcp.0000000000000372","mag":"2439951792","pmid":"https://pubmed.ncbi.nlm.nih.gov/26244381","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4553101"},"language":"en","primary_location":{"id":"doi:10.1097/jcp.0000000000000372","doi":"https://doi.org/10.1097/jcp.0000000000000372","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000000372","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2439951792"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4553101","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090066496","display_name":"David J. McCann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David J. McCann","raw_affiliation_strings":["From the *Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, NIH, Bethesda, MD; \u2020Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT; and \u2021Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA","Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the *Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, NIH, Bethesda, MD; \u2020Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT; and \u2021Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482","https://openalex.org/I140172145"]},{"raw_affiliation_string":"Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085905942","display_name":"Nancy M. Petry","orcid":"https://orcid.org/0000-0003-2462-1752","observed_orcids":["https://orcid.org/0000-0003-2462-1752"]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]},{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy M. Petry","raw_affiliation_strings":["Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT","institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060033096","display_name":"Anders Bresell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anders Bresell","raw_affiliation_strings":["Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022773830","display_name":"Eva Isacsson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Isacsson","raw_affiliation_strings":["Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070336786","display_name":"Ellis Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellis Wilson","raw_affiliation_strings":["Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103079586","display_name":"Robert Alexander","orcid":"https://orcid.org/0000-0002-6889-2952","observed_orcids":["https://orcid.org/0000-0002-6889-2952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert C. Alexander","raw_affiliation_strings":["Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovative Medicines, Neurosciences, AstraZeneca, Cambridge, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5090066496"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482","https://openalex.org/I140172145"],"apc_list":null,"apc_paid":null,"fwci":0.727,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.4962963,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"35","issue":"5","first_page":"566","last_page":"573"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.5342000126838684,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.5342000126838684,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.31790000200271606,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.06729999929666519,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medication-non-adherence","display_name":"medication non-adherence","score":0.9980000257492065},{"id":"https://openalex.org/keywords/professional-subjects","display_name":"professional subjects","score":0.9129999876022339},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.6420000195503235},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.5180000066757202},{"id":"https://openalex.org/keywords/psychiatric-drug-trials","display_name":"psychiatric drug trials","score":0.7590000033378601},{"id":"https://openalex.org/keywords/sample-size","display_name":"sample size","score":0.39899998903274536},{"id":"https://openalex.org/keywords/statistical-power","display_name":"statistical power","score":0.9070000052452087},{"id":"https://openalex.org/keywords/effect-size","display_name":"effect size","score":0.546999990940094},{"id":"https://openalex.org/keywords/clinical-trial-monitoring","display_name":"clinical trial monitoring","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.761287271976471},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7541347742080688},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6626148223876953},{"id":"https://openalex.org/C129848803","wikidata":"https://www.wikidata.org/wiki/Q2564360","display_name":"Sample size determination","level":2,"score":0.59979647397995},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44659820199012756},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.42945975065231323},{"id":"https://openalex.org/C2779318504","wikidata":"https://www.wikidata.org/wiki/Q1438035","display_name":"Research design","level":2,"score":0.4152091145515442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3369450569152832},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2956041097640991},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018401","descriptor_name":"Sample Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035842","descriptor_name":"Research Subjects","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/jcp.0000000000000372","doi":"https://doi.org/10.1097/jcp.0000000000000372","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000000372","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:26244381","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26244381","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:3998185","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4553101","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4553101","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4553101/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Psychopharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3998185","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4553101","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5822212881","display_name":"Etiology and Treatment of Alcohol Dependence","funder_award_id":"P60AA003510","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"},{"id":"https://openalex.org/G6969890512","display_name":null,"funder_award_id":"Z99 DA999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337330","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W172027523","https://openalex.org/W1558780294","https://openalex.org/W1609772988","https://openalex.org/W1723390637","https://openalex.org/W1943599437","https://openalex.org/W1968992146","https://openalex.org/W1972110417","https://openalex.org/W1973487017","https://openalex.org/W1975415740","https://openalex.org/W1975493131","https://openalex.org/W1982206307","https://openalex.org/W1998637571","https://openalex.org/W2006801926","https://openalex.org/W2007022438","https://openalex.org/W2009994290","https://openalex.org/W2010446962","https://openalex.org/W2021516828","https://openalex.org/W2022132912","https://openalex.org/W2022928755","https://openalex.org/W2024700745","https://openalex.org/W2033806581","https://openalex.org/W2034279065","https://openalex.org/W2039786436","https://openalex.org/W2043268173","https://openalex.org/W2043433089","https://openalex.org/W2044343275","https://openalex.org/W2045106443","https://openalex.org/W2045126365","https://openalex.org/W2046479879","https://openalex.org/W2047798141","https://openalex.org/W2055899096","https://openalex.org/W2058400556","https://openalex.org/W2063780338","https://openalex.org/W2065812641","https://openalex.org/W2065962849","https://openalex.org/W2066098642","https://openalex.org/W2067057773","https://openalex.org/W2071735605","https://openalex.org/W2073526412","https://openalex.org/W2080635711","https://openalex.org/W2083132149","https://openalex.org/W2084641088","https://openalex.org/W2086486182","https://openalex.org/W2087620561","https://openalex.org/W2095706156","https://openalex.org/W2107132318","https://openalex.org/W2113494811","https://openalex.org/W2136211460","https://openalex.org/W2137999875","https://openalex.org/W2145355470","https://openalex.org/W2152599125","https://openalex.org/W2159271064","https://openalex.org/W2165587373","https://openalex.org/W2166209362","https://openalex.org/W2166550586","https://openalex.org/W2167635958","https://openalex.org/W2167761850","https://openalex.org/W2188387284","https://openalex.org/W2393834324","https://openalex.org/W2412202816","https://openalex.org/W2437822687","https://openalex.org/W2911964244","https://openalex.org/W3034187217","https://openalex.org/W3125730391","https://openalex.org/W4230788116","https://openalex.org/W4246475368","https://openalex.org/W4256538889","https://openalex.org/W6606966867"],"related_works":["https://openalex.org/W2194276201","https://openalex.org/W4415249687","https://openalex.org/W2895372591","https://openalex.org/W2583501307","https://openalex.org/W1978698495","https://openalex.org/W3039757093","https://openalex.org/W2890557856","https://openalex.org/W2846895012","https://openalex.org/W2096947327","https://openalex.org/W2319857693"],"abstract_inverted_index":{"Nonadherence":[0],"is":[1,129],"a":[2,67,219],"major":[3],"problem":[4],"in":[5,72,102,123],"clinical":[6,221],"trials":[7,31,97,124],"of":[8,15,44,50,57,77,117,138,150,167,197,229],"new":[9],"medications.":[10],"To":[11],"evaluate":[12],"the":[13,48,55,136,175,181,190,226],"extent":[14],"nonadherence,":[16,198],"this":[17,215],"study":[18,53,89,168],"evaluated":[19],"pharmacokinetic":[20],"sampling":[21],"from":[22,61],"1765":[23],"subjects":[24,59,106,140,152,231],"receiving":[25],"active":[26],"therapy":[27],"across":[28],"8":[29],"psychiatric":[30],"conducted":[32],"between":[33],"2001":[34],"and":[35,132,180,201,211,235],"2011.":[36],"With":[37],"nonadherence":[38,71,83],"defined":[39],"as":[40],"greater":[41,75],"than":[42],"50%":[43],"plasma":[45],"samples":[46],"below":[47],"limit":[49],"quantification":[51],"for":[52,87,126,185],"drug,":[54],"percentage":[56],"nonadherent":[58],"ranged":[60],"12.8%":[62],"to":[63,108,156,162,224,238],"39.2%.":[64],"There":[65],"was":[66,84],"trend":[68],"toward":[69],"increased":[70],"studies":[73],"with":[74,82,98],"numbers":[76],"subjects,":[78,200],"but":[79],"an":[80],"association":[81],"not":[85],"apparent":[86,176],"other":[88],"design":[90,223],"parameters":[91],"or":[92],"subject":[93],"characteristics.":[94],"For":[95],"2":[96],"multiple":[99],"recruitment":[100],"sites":[101],"geographical":[103],"proximity,":[104],"several":[105],"attempted":[107],"simultaneously":[109],"enroll":[110,122],"at":[111],"separate":[112],"site":[113],"locations.":[114],"The":[115,145,194],"construct":[116],"\"professional":[118],"subjects,\"":[119],"those":[120],"who":[121,153,159],"only":[125],"financial":[127],"gain,":[128],"gaining":[130],"attention,":[131],"we":[133,217],"therefore":[134],"modeled":[135],"impact":[137],"professional":[139,151,199,230],"on":[141,232],"medication":[142],"efficacy":[143],"trials.":[144],"results":[146],"indicate":[147],"that":[148,205],"enrollment":[149],"are":[154],"destined":[155],"succeed":[157],"(those":[158],"will":[160],"appear":[161],"achieve":[163],"treatment":[164],"success":[165],"regardless":[166],"drug":[169],"assignment)":[170],"can":[171],"substantially":[172],"increase":[173],"both":[174],"placebo":[177,202],"response":[178,203],"rate":[179],"sample":[182],"size":[183],"requirement":[184],"statistical":[186],"power,":[187],"while":[188],"decreasing":[189],"observed":[191],"effect":[192],"size.":[193],"overlapping":[195],"nature":[196],"suggests":[204],"these":[206],"issues":[207],"should":[208],"be":[209],"considered":[210],"addressed":[212],"together.":[213],"Following":[214],"approach,":[216],"describe":[218],"novel":[220],"trial":[222,233],"minimize":[225],"adverse":[227],"effects":[228],"outcomes":[234],"discuss":[236],"methods":[237],"monitor":[239],"adherence.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2439951792","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
